Edges in Network
| Network | GSE16391_egf1520 - GSE16391 - SiGN-BN HC+Bootstrap |
| Network Description | GGI: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1-98 trial |
| Node | SLC25A25 |
| Upstream (Parents) |
|---|
| (<<) ARHGEF2 → SLC25A25 |
| (<<) DNAJA1 → SLC25A25 |
| (<<) FAM131C → SLC25A25 |
| (<<) FBXO32 → SLC25A25 |
| (<<) FUT1 → SLC25A25 |
| (<<) HRAS → SLC25A25 |
| (<<) MAP3K4 → SLC25A25 |
| (<<) SOD1 → SLC25A25 |
| Downstream (Children) |
|---|
| SLC25A25 → CCDC108 (>>) |
| SLC25A25 → DUSP2 (>>) |
| SLC25A25 → EFEMP1 (>>) |
| SLC25A25 → LEMD1 (>>) |
| SLC25A25 → NAGS (>>) |
| SLC25A25 → NOC3L (>>) |
| SLC25A25 → NRIP3 (>>) |
| SLC25A25 → PARP10 (>>) |
| SLC25A25 → RNASE7 (>>) |
| SLC25A25 → STK11 (>>) |
